Olin D. Liang Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

John Brown University

faculty

29 h-index 86 pubs 6,002 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Dr. Olin D. Liang conducts research into pulmonary hypertension and the role of cell adhesion molecules in disease at John Brown University. Liang's work spans multiple facets of disease pathology, from protease and inhibitor mechanisms to the involvement of extracellular vesicles. His work has contributed to the understanding of potential treatments for pulmonary arterial hypertension through the targeting of RUNX1. Liang also investigates the intersection of COVID-19 with preexisting conditions, including the role of aging and therapeutic targets like Chitinase 3-like-1. Recent publications have also explored the role of NF-κB signaling in neoplastic transition and the impact of *SOX17* enhancer variants on pulmonary hypertension.

Liang's primary research interests lie in pulmonary hypertension research and treatments.

Metrics

  • h-index: 29
  • Publications: 86
  • Citations: 6,002

Selected Publications

  • Myeloid Specific Ablation of SHIP1 Boosts ex vivo Expansion and Regulatory Function of Myeloid-Derived Suppressor Cells in Inflammatory Arthritis (2025) DOI
  • Enabling CAR-T Cell Immunotherapy in Glioblastoma by Modifying Tumor Microenvironment via Oncolytic Adenovirus Encoding Bispecific T Cell Engager (2025) DOI
  • Proximity Proteomics Reveals New Roles of Abelson Interactor 1 in Centrosome Function and Inflammatory Signaling (2022) DOI
  • Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19 (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics